Publicacions
-
Martín-Muñoz MF, Alonso Lebrero E, Zapatero L, Fuentes Aparicio V, Piquer-Gibert M, Plaza-Martín AM, Muñoz C, Belver MT, Martorell-Calatayud C, Martorell-Aragonés A, Blasco C, Vilá B, Gómez C, Nevot S, García Martín JM, Madero R and Echeverría L.
Egg OIT in clinical practice (SEICAP II): Maintenance patterns and desensitization state after normalizing the diet
PEDIATRIC ALLERGY AND IMMUNOLOGY . 30(2): 214-224. Nº de cites: 15
-
Patterson K, Iglesias-Jimenez E, Nasrallah M, González V, Suñol M, Anton-Lopez J, Saiz A, Lancaster E and Armangue-Salvador T.
Anti-MOG encephalitis mimicking small vessel CNS vasculitis
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 6(2): 538. Nº de cites: 52
-
Foeldvari, I, Klotsche, J, Torok, KS, Kasapcopur, O, Adrovic, A, Stanevicha, V, Terreri, MT, Alexeeva, E, Katsicas, M, Cimaz, R, Kostik, M, Lehman, T, Sifuentes-Giraldo, WA, Smith, V, Sztajnbok, F, Avcin, T, Santos, MJ, Moll, M, Nemcova, D, Battagliotti, C, Eleftheriou, D, Janarthanan, M, Kallinich, T, Anton-Lopez J, Minden, K, Nielsen, S, Uziel, Y and Helmus, N.
Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort
Journal of Scleroderma and Related Disorders . 4(1): 49-61. Nº de cites: 19
-
Martín-Muñoz MF, Belver MT, Alonso Lebrero E, Zapatero Remón L, Fuentes Aparicio V, Piquer-Gibert M, Plaza-Martín AM, Muñoz Román C, Martorell-Calatayud C, Martorell-Aragonés A, Blasco C, Vilá B, Gómez C, Nevot S, García Martinez JM, Madero Jarabo R and Echeverria L.
Egg oral immunotherapy in children (SEICAP I): Daily or weekly desensitization pattern
PEDIATRIC ALLERGY AND IMMUNOLOGY . 30(1): 81-92. Nº de cites: 28
-
Mariño-Sánchez F, Valls-Mateus M, de Los Santos G, Plaza-Martín AM, Cobeta I and Mullol J.
Multimorbidities of Pediatric Allergic Rhinitis
CURRENT ALLERGY AND ASTHMA REPORTS . 19(2): 13-13. Nº de cites: 17
-
Navallas M, Inarejos E, Iglesias-Jimenez E, Rebollo M, Anton-Lopez J and Navarro OM.
Connective Tissue Disorders in Childhood: Are They All the Same?
RADIOGRAPHICS . 39(1): 229-250. Nº de cites: 8
-
Mensa-Vilaró A, Bravo M, de la Calle-Martin O, Franco-Jarava C, Martínez-Saavedra MT, González-Granado LI, González-Roca E, Fuster JL, Alsina L, Mutchinick OM, Balderrama-Rodríguez A, Ramos E, Modesto C, Mesa-Del-Castillo P, Ortego-Centeno N, Clemente D, Souto A, Palmou N, Remesal A, Leslie KS, Gómez de la Fuente E, Bravo Gallego LY, Campistol JM, Dhouib NG, Bejaoui M, Dutra LA, Terreri MT, Mosquera C, González T, Cañellas J, García-Ruiz de Morales JM, Wouters CH, Bosque MT, Cham WT, Jiménez-Treviño S, de Inocencio J, Bloomfield M, Pérez de Diego R, Martínez-Pomar N, Rodríguez-Pena R, González-Santesteban C, Soler-Palacín P, Casals F, Yagüe J, Allende LM, Rodríguez-Gallego JC, Colobran R, Martínez-Martínez L, López-Granados E and Aróstegui JI.
Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY . 143(1): 359-368. Nº de cites: 50
-
Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva E, Panaviene V, Bader-Meunier B, Anton-Lopez J, Nielsen S, De Benedetti F, Kamphuis S, Stanevica V, Tracahana M, Ailioaie LM, Tsitsami E, Klein A, Minden K, Foeldvari I, Haas JP, Klotsche J, Horne AC, Consolaro A, Bovis F, Bagnasco F, Pistorio A, Martini A, Wulffraat N, Ruperto N and Paediatric Rheumatology International Trials Organisation (PRINTO), BiKeR and th.
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries.
ARTHRITIS RESEARCH & THERAPY . 20(1): 285-285. Nº de cites: 69
-
Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat NM, Horneff G, Kasapcopur O, Schneider R, Anton-Lopez J, Barash J, Berner R, Corona F, Cuttica R, Fouillet-Desjonqueres M, Fischbach M, Foster HE, Foell D, Radominski SC, Ramanan AV, Trauzeddel R, Unsal E, Levy J, Vritzali E, Martini A and Lovell DJ.
Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials.
ANNALS OF THE RHEUMATIC DISEASES . 77(12): 1710-1719. Nº de cites: 69
-
Casas-Alba D, Martinez-Monseny T, Pino-Ramirez RM, Alsina L, Castejón Ponce E, Navarro S, Pérez-Dueñas B, Serrano M, Palau F and García-Alix A.
Hyaline fibromatosis syndrome: Clinical update and phenotype-genotype correlations
HUMAN MUTATION . 39(12): 1752-1763. Nº de cites: 28